Successful trials of implant to prevent OAB

I reported previously (July 2016) that the minimally invasive RENOVA leg implant from Israel’s BlueWind to treat Overactive Bladder (OAB) had been granted European approval. Recent trials show that device gave over 50% improvement to 71% of participants.

https://www.prnewswire.com/news-releases/bluewind-medical-announces-the-publication-of-breakthrough-results-for-bluewind-renova-implantable-tibial-nerve-neuromodulator-668016233.html

http://www.bluewindmedical.com/products

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *